M. A. Burnett - Concepedia

Author

M. A. Burnett

Oxford Centre for Diabetes, Endocrinology and Metabolism

Also Known As

M Burnett, M. A. BURNETT, M. A. Burnett, M. Burnett, M.A. Burnett, MELANIE A. BURNETT, Melanie A. Burnett, Melanie Burnett, William Mahle

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford John Radcliffe Hospital

About

M. A. Burnett is an author at Oxford Centre for Diabetes, Endocrinology and Metabolism specializing in diabetes, medicine, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.5K
2	Health Sciences	8	8	1.2K
3	Biochemistry	1	1	39
4	Biomedical Engineering	1	1	286
5	Biostatistics	1	1	38

M. A. Burnett

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Continuous infusion of glucose with model assessment: measurement of insulin resistance and ?-cell function in man J P Hosker, David R. Matthews, A. Rudenski, Diabetologia Insulin ResistanceMetabolic SyndromeDiabetes ManagementBody CompositionInsulin Management	1985	286
Brief, Irregular Oscillations of Basal Plasma Insulin and Glucose Concentrations in Diabetic Man D. Lang, David R. Matthews, M. A. Burnett, Diabetes Metabolic SyndromeDiabetes ManagementInsulin OscillationsKinesiologyHealth Sciences	1981	269
BETA-CELL DYSFUNCTION, RATHER THAN INSULIN INSENSITIVITY, IS THE PRIMARY DEFECT IN FAMILIAL TYPE 2 DIABETES Stephen O’Rahilly, A. Rudenski, M. A. Burnett, The Lancet ObesityMetabolic SyndromeInsulin ResistanceDiabetesPathology	1986	233
Control of pulsatile insulin secretion in man David R. Matthews, D. Lang, M. A. Burnett, Diabetologia Metabolic SyndromeInsulin ManagementPhysiologyDiabetesPulsatile Insulin Secretion	1983	178
Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure J.K. Cruickshank, J. MacDuff, U. Drubra, The Lancet ObesityMetabolic SyndromeHypertensionDiabetes EpidemiologyMetabolic Disorder	1991	155
Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy John Hosker, Aram S. Rudenski, M. A. Burnett, Metabolism Metabolic SyndromeDiabetes ManagementMedicinePhysiologyHematology	1989	125
Pulsatile, Synchronous Basal Insulin and Glucagon Secretion in Man D. Lang, David R. Matthews, M. A. Burnett, Diabetes	1982	114
Haemolysis affects insulin but not C-peptide immunoassay Stephen O’Rahilly, M. A. Burnett, Robin Smith, Diabetologia Insulin ManagementPhysiologyImmunologyDiabetesAutoimmunity	1987	72
THE HALF‐LIFE OF ENDOGENOUS INSULIN AND C‐PEPTIDE IN MAN ASSESSED BY SOMATOSTATIN SUPPRESSION David R. Matthews, A. Rudenski, M. A. Burnett, Clinical Endocrinology	1985	71
Sulphonylurea therapy doubles B-cell response to glucose in Type 2 diabetic patients J P Hosker, M. A. Burnett, Eleanor Davies, Diabetologia Metabolic SyndromeDiabetes ManagementSulphonylurea TherapyMedicineInsulin Management	1985	48

Page 1